Under pressure: should Pharma bite the (magic) bullet?
The business model of big Pharma is under threat. The future lies with integrated care models, says 72 per cent of top executives in a recent INSEAD survey, and that Pharma must move away from marketing and ‘pill pushing’. psHEALTH agrees. We believe most companies will need to develop services to augment existing therapy areas. In the long-term, success may be found in entirely new, ambitious service offerings for 21st- century healthcare.
Payment by Results – How to Offer More for Less
For everyone involved in delivering NHS care, there is little doubt about the direction of travel: commissioners are expanding the use of Payment by Results. The next step will be the introduction of Year-of-Care tariffs for long-term conditions. To prosper in this new environment your organisation will need to measure outcomes (~revenue) and understand activity (~cost) at the patient level. Armed with this information you will be able to design services that deliver better healthcare and an improved profit & loss statement.
Clinical Governance: Is your team playing by the rules?
You spend a lot of time developing your clinical protocols. But how do you know that your nurses and doctors actually comply?
Not only is compliance vital for best practice, but you need to know your house is in order before the Care Quality Commission comes knocking…